Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health intends to negotiate a sole source acquisition for the GLOMAX(R) Discover System and dual injectors with pumps from Promega Corporation. This is critical for ongoing research at the Clinical Center, and responses from other potential sources are welcome by the specified deadline.
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Promega Corporation.
Acquisition Description:
Order is associated with research investigations that are central to the mission of the Clinical Center and the NIH. Failure to fulfill would jeopardize time-sensitive experiments & would waste already-invested funds.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-007847) by 12:00 PM eastern standard time on 07/23/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
GLOMAX(R) DISCOVER SYSTEM AND DUAL INJECTORS WITH PUMPS is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.